Steroid-refractory acute graft-versus-host disease (SR-aGVHD) treatment has a low response rate and a high risk of infection in allogeneic hematopoietic stem cell transplantation. The standard approach to be applied in this situation is uncertain. This study aims to evaluate the effectiveness and safety of alpha-1-antitrypsin (AAT). In the study, the results of five SR-aGVHD patients received AAT evaluated. Complete response was seen 2 of four patients with gastrointestinal (GI) aGVHD, partial response in one GI and one liver aGVHD. The overall response rate was 80%. AAT is an effective and safe treatment option in SR-aGVHD.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209553 | PMC |
| http://dx.doi.org/10.1007/s12288-022-01524-2 | DOI Listing |
Publication Analysis
Top Keywords
acute graft-versus-host
8
graft-versus-host disease
8
response rate
8
alpha-1-antitrypsin experience
4
experience steroid-resistant
4
steroid-resistant acute
4
disease steroid-refractory
4
steroid-refractory acute
4
disease sr-agvhd
4
sr-agvhd treatment
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!